Lessee, Operating Lease, Liability, to be Paid, Year One in USD of Neuphoria Therapeutics Inc. from Q2 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Neuphoria Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q2 2024 to Q2 2025.
  • Neuphoria Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Jun 2025 was $119,593, a 38.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $119,593 -$73,813 -38% 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q1 2025 $114,663 31 Mar 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 $113,512 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2
Q3 2024 $182,584 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $193,406 30 Jun 2024 10-K 30 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.